A phase 2 study published in the New England Journal of Medicine described retatrutide as a triple-hormone receptor agonist for obesity
Users report visible results, including a healthy glow, and appreciate its quality and easy consumption
6 Safety and tolerability 6.1 Adverse events reported in clinical trials Tirzepatide offers therapeutic benefits and demonstrates a safety profile comparable to that of other incretin-based therapies, such as semaglutide and dulaglutide (Jung and Jung 2022)
Failure to Warn Allegations Lawsuits against Novo Nordisk and Eli Lilly are built on allegations that both pharmaceutical companies failed to properly warn consumers about the health risks tied to their GLP-1 drugs
Glutathione levels tend to decline with age, and research has suggested a potential link between low glutathione levels and age-related diseases, such as cardiovascular disease, neurodegenerative disorders, and cancer
Our platform connects patients with licensed providers who may prescribe compounded semaglutide, and this semaglutide online guide walks through how that access process works
